Literature DB >> 23135221

Pioglitazone and risk of bladder cancer: clarification of the design of the French study.

A T Perez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23135221     DOI： 10.1007/s00125-012-2767-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  2 in total

1.  Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

Authors:  James D Lewis; Assiamira Ferrara; Tiffany Peng; Monique Hedderson; Warren B Bilker; Charles P Quesenberry; David J Vaughn; Lisa Nessel; Joseph Selby; Brian L Strom
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

2.  Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study.

Authors:  A Neumann; A Weill; P Ricordeau; J P Fagot; F Alla; H Allemand
Journal:  Diabetologia       Date:  2012-03-31       Impact factor: 10.122
  2 in total
  2 in total

1.  Pioglitazone and risk of bladder cancer: clarification of the design of the French study. Reply to Perez AT [letter].

Authors:  A Neumann; A Weill; P Ricordeau; J P Fagot; F Alla; H Allemand
Journal:  Diabetologia       Date:  2012-11-11       Impact factor: 10.122

2.  Pioglitazone: A prudent prescription.

Authors:  Sanjay Kalra; Puneet Dhamija; Rakesh Sahay
Journal:  Indian J Endocrinol Metab       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.